Oncternal Therapeutics's Stock Price And Volume Action
Oncternal Therapeutics's ONCT stock has been rising Wednesday, up 4.61% to a price of $9.13. The stock's volume is currently 126.68 thousand, which is roughly 8.74% of its recent 30-day volume average of 1.45 million.
Why It's Moving
Benzinga Pro's real-time breaking news service shows some insight into what is affecting shares: Oncternal Therapeutics shares are trading higher after Oppenheimer initiated coverage on the stock with an Outperform rating and announced a $14 price target.
Perspective On Recent Price Action
The moving average price of the stock over the past 50 days was $7.12 at the time this article was published. In the past fifty-two weeks, the stock price has been as high as $9.45 and as low as $1.49.
If you're looking for timely and concise explanations of why a stock is moving, check out Benzinga Pro. Subscribers get ‘Why Is It Moving' alerts as soon as our research team identifies the cause of the price action in a stock. Click here to learn more.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.